Cloud-Based Scientific Literature Content and Management Platform
The submission route named on the official notice.
The Cell and Gene Therapy Catapult is requesting a cloud-based scientific literature content and management platform.
The platform should provide all staff with efficient access to scholarly articles, research papers, and other relevant business, pharmaceutical and regulatory content.
The contract will be for a one-year period, with the option to extend for two further one-year periods (1+1+1)
What the supplier must deliver
The platform should provide all staff
The platform should provide all staff with efficient access to scholarly articles, research papers, and other relevant business, pharmaceutical and regulatory content.
Derived from the notice text — always confirm against the original documents.
Make the case to bid
Reveal who to approach at Cell & Gene Therapy Catapult, and generate a go-to-market strategy from their news, accounts and people.
The full intelligence dossier
Our agent reads Cell & Gene Therapy Catapult’s accounts, hunts live signals, finds the people who decide — and hands you a bid strategy plus a go-to-market influence plan, including what your team should post this week. You approve every paid step.
Ask me about this tender, the buyer, who wins their work, or whether you should bid.
- OCID
- ocds-h6vhtk-06d252
- Stage
- tender · Open
- Source
- Find a Tender
- Buyer ref
- 069877-2026
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Software & IT Systems
Cell & Gene Therapy Catapult’s tender network
Assembling the network…